Altimmune GAAP EPS of -$0.12 beats by $0.02
Altimmune's GAAP EPS beat expectations, recording a profitability/improved surprise in its earnings announcement.
The buy entry was considered based on positive earnings news (EPS beats) and the recent 7-day low and closing price movements of the candlesticks. Since no specific numerical basis was provided for support and resistance levels, the judgment focused on the provided news data, the RSI of 61.6, and volume indicators.
Consider scaled profit-taking when the profit target of $3.31 is reached, and if the condition breaks down—i.e., the price falls below the stop-loss level of $2.75—I will respond immediately with a stop-loss. These profit-taking and stop-loss prices are values generated by REPORTING.
Technical indicators at the time of entry are confirmed as follows: RSI(14) at 61.6, moving averages not in bullish alignment, trading volume at 0.78x the 20-day average, and a 7-day change of +3.9%. The RSI is in the mid-60s, a range where buying pressure is dominant, while trading volume falls short of the average and the moving averages are not in bullish alignment.
In the historical record of this stock, the post-event reaction rates following similar events were +8.3% on 2026-08-13, +6.5% on 2026-08-12, and +2.7% on 2026-07-28. Past price reactions of this stock to events showed positive performance; however, detailed trading volume and short-selling data are not available.
The trade closed as an OVERHIT, delivering an actual return of 14.0% that exceeded the anticipated 2.5%. The entry was attempted on the back of the positive earnings announcement (GAAP EPS -$0.12 beats by $0.02), supported by an RSI of 61.6 and an upward candlestick trend over the recent 7 days (+3.9%). However, with trading volume somewhat light at 0.78x the 20-day average, we had expected a subdued flow rather than strong buying inflow; yet, as seen in past volatility patterns such as +8.3% and +6.5%, the stock's characteristic upside elasticity appears to have erupted far more strongly than anticipated.
In this trade, the positive news figures and the short-term candlestick volatility (+3.9%) were accurately captured; however, I note that individual stock momentum acted strongly despite theme news showing a declining trend (falling), with 23 items versus the previous 40. Going forward, even if news flow for the theme as a whole slows somewhat, if the stock's characteristic of exhibiting strong upward reactions in past similar events is confirmed, I should keep the target price somewhat more flexible or actively employ a scaled profit-taking strategy to maximize returns.